Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

Relation between smoking history and gene expression profiles in lung adenocarcinomas.

Staaf J, Jönsson G, Jönsson M, Karlsson A, Isaksson S, Salomonsson A, Pettersson HM, Soller M, Ewers SB, Johansson L, Jönsson P, Planck M.

BMC Med Genomics. 2012 Jun 7;5:22.

PMID:
22676229
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.

PMID:
16915569
[PubMed - indexed for MEDLINE]
3.

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, Lam S, Gazdar AF, Laird-Offringa IA.

Genome Res. 2012 Jul;22(7):1197-211. doi: 10.1101/gr.132662.111. Epub 2012 May 21.

PMID:
22613842
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.

Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA.

Int J Cancer. 2005 Apr 10;114(3):400-5.

PMID:
15578700
[PubMed - indexed for MEDLINE]
5.

Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.

Boelens MC, van den Berg A, Fehrmann RS, Geerlings M, de Jong WK, te Meerman GJ, Sietsma H, Timens W, Postma DS, Groen HJ.

J Pathol. 2009 Jun;218(2):182-91. doi: 10.1002/path.2520.

PMID:
19334046
[PubMed - indexed for MEDLINE]
6.

Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers.

Lam DC, Girard L, Suen WS, Chung LP, Tin VP, Lam WK, Minna JD, Wong MP.

J Thorac Oncol. 2006 Nov;1(9):932-42.

PMID:
17409975
[PubMed - indexed for MEDLINE]
7.

Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.

Karlsson A, Ringnér M, Lauss M, Botling J, Micke P, Planck M, Staaf J.

Clin Cancer Res. 2014 Sep 15;20(18):4912-24. doi: 10.1158/1078-0432.CCR-14-0246. Epub 2014 Jul 18.

PMID:
25037737
[PubMed - in process]
8.

Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq.

Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A.

Cancer Prev Res (Phila). 2011 Jun;4(6):803-17. doi: 10.1158/1940-6207.CAPR-11-0212.

PMID:
21636547
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Gene expression in lung adenocarcinomas of smokers and nonsmokers.

Powell CA, Spira A, Derti A, DeLisi C, Liu G, Borczuk A, Busch S, Sahasrabudhe S, Chen Y, Sugarbaker D, Bueno R, Richards WG, Brody JS.

Am J Respir Cell Mol Biol. 2003 Aug;29(2):157-62. Epub 2003 Feb 21.

PMID:
12600827
[PubMed - indexed for MEDLINE]
10.

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.

Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, Murphy SE, Yang P, Pesatori AC, Consonni D, Bertazzi PA, Wacholder S, Shih JH, Caporaso NE, Jen J.

PLoS One. 2008 Feb 20;3(2):e1651. doi: 10.1371/journal.pone.0001651.

PMID:
18297132
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.

Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba II.

PLoS One. 2010 Feb 9;5(2):e9112. doi: 10.1371/journal.pone.0009112.

PMID:
20161759
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Gene expression subtraction of non-cancerous lung from smokers and non-smokers with adenocarcinoma, as a predictor for smokers developing lung cancer.

Stav D, Bar I, Sandbank J.

J Exp Clin Cancer Res. 2008 Sep 24;27:45. doi: 10.1186/1756-9966-27-45.

PMID:
18811983
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genomic aberrations in lung adenocarcinoma in never smokers.

Job B, Bernheim A, Beau-Faller M, Camilleri-Broët S, Girard P, Hofman P, Mazières J, Toujani S, Lacroix L, Laffaire J, Dessen P, Fouret P; LG Investigators.

PLoS One. 2010 Dec 6;5(12):e15145. doi: 10.1371/journal.pone.0015145.

PMID:
21151896
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.

Cancer Res. 2003 Aug 15;63(16):4842-8.

PMID:
12941804
[PubMed - indexed for MEDLINE]
Free Article
15.

Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer.

Wang X, Chorley BN, Pittman GS, Kleeberger SR, Brothers J 2nd, Liu G, Spira A, Bell DA.

PLoS One. 2010 Aug 3;5(8):e11934. doi: 10.1371/journal.pone.0011934.

PMID:
20689807
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.

Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G.

Chest. 2004 Aug;126(2):347-51.

PMID:
15302716
[PubMed - indexed for MEDLINE]
17.

Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.

Guo NL, Wan YW.

Artif Intell Med. 2012 Jun;55(2):97-105. doi: 10.1016/j.artmed.2012.01.001. Epub 2012 Feb 11.

PMID:
22326768
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma.

Fouret R, Laffaire J, Hofman P, Beau-Faller M, Mazieres J, Validire P, Girard P, Camilleri-Bröet S, Vaylet F, Leroy-Ladurie F, Soria JC, Fouret P.

Clin Cancer Res. 2012 Oct 15;18(20):5606-16. doi: 10.1158/1078-0432.CCR-12-0505. Epub 2012 Aug 22.

PMID:
22914773
[PubMed - indexed for MEDLINE]
Free Article
19.

K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.

Westra WH, Slebos RJ, Offerhaus GJ, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhuis S, Hruban RH.

Cancer. 1993 Jul 15;72(2):432-8.

PMID:
8319174
[PubMed - indexed for MEDLINE]
20.

Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers.

Dutu T, Michiels S, Fouret P, Penault-Llorca F, Validire P, Benhamou S, Taranchon E, Morat L, Grunenwald D, Le Chevalier T, Sabatier L, Soria JC.

Ann Oncol. 2005 Dec;16(12):1906-14. Epub 2005 Oct 11.

PMID:
16219624
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk